Editorial: 10-year data on oral selexipag: Long-term survival, safety, and dosing insights in pulmonary arterial hypertension from the GRIPHON study and its open-label extension–big data-small impact

View at publisher
Authors: Irene Marthe Lang
Cited by: 0
References: 7

Fields of Study & Subjects

Pulmonary Hypertension Research and Treatments Vascular Anomalies and Treatments Heart Failure Treatment and Management

Publication details

Journal / source
The Journal of Heart and Lung Transplantation
Volume
45
Issue
5
Pages
847–848
Publication date
4 February 2026
Language
EN